10321 Results for "

in

" in MedChemExpress (MCE) Product Catalog:
Products (10321)

10321 Results for "in" in MCE Product Catalog:

59
59 Publications Verification
Cat. No.: HY-13319
CAS No.: 1410880-22-6
Purity:  99.67%
Synonyms: JNK inhibitor XVI
Target:  

JNK

연구분야:  

Cancer

JNK-IN-8 (JNK Inhibitor XVI) is a potent JNK inhibitor with IC50s of 4.7 nM, 18.7 nM, and 1 nM for JNK1, JNK2, and JNK3, respectively .
loading...
    loading...
35
35 Cited Publications
Cat. No.: HY-138489
CAS No.: 1424635-83-5
Purity:  99.22%
Synonyms: Lats-in-1
연구분야:  

Others

TRULI (Lats-IN-1) is a potent and ATP-competitive inhibitor of Lats1 and Lats2 kinases. TRULI promotes Yap-dependent proliferation in postmitotic mammalian tissues .
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-101853
CAS No.: 285986-31-4
Purity:  98.35%
Target:  

STAT

연구분야:  

Cancer

STAT5-IN-1 is a STAT5 inhibitor with an IC50 of 47 μM for STAT5β isoform.
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-P7077
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL2; T Cell Growth Factor; interleukin 2; Aldesleukin; IL-2; involved in Regulation Of T-Cell Clonal Expansion; TCGF; T-Cell Growth Factor; interleukin-2; Lymphokine
Species:  
Mouse
Source:  
E. coli
loading...
    loading...
30
30 Cited Publications
Cat. No.: HY-103617
CAS No.: 94164-88-2
Purity:  99.79%
Target:  

Pyruvate Kinase

연구분야:  

Cancer

PKM2-IN-1 (compound 3k) is a pyruvate kinase M2 (PKM2) inhibitor with an IC50 of 2.95 μM .
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-100877
CAS No.: 1448693-69-3
Purity:  ≥98.0%
연구분야:  

Cancer

GCN2-IN-1 is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with an IC50 of <0.3 μM in the enzyme assay and an IC50 of 0.3-3 μM in the cell assay .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-12836
CAS No.: 844882-93-5
Target:  

IFNAR

연구분야:  

Inflammation/Immunology

IFN alpha-IFNAR-IN-1 is a nonpeptidic, low-molecular-weight inhibitor of the interaction between IFN-α and IFNAR. IFN alpha-IFNAR-IN-1 inhibits modified Vaccinia virus ankara (MVA)-induced IFN-α responses in murine bone-marrow-derived, Flt3- L-differentiated pDC cultures (BM-pDCs) (IC50=2-8 μM) .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-12836A
CAS No.: 2070014-98-9
Purity:  99.76%
Target:  

IFNAR

연구분야:  

Inflammation/Immunology

IFN alpha-IFNAR-IN-1 hydrochloride is a nonpeptidic, low-molecular-weight inhibitor of the interaction between IFN-α and IFNAR. IFN alpha-IFNAR-IN-1 hydrochloride inhibits modified Vaccinia virus ankara (MVA)-induced IFN-α responses in murine bone-marrow-derived, Flt3- L-differentiated pDC cultures (BM-pDCs) (IC50=2-8 μM) .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-B0322B
CAS No.: 723-46-6
Synonyms: Ro 4-2130 1000 µg/mL in methanol
Target:  

Antibiotic Bacterial

연구분야:  

Infection

Sulfamethoxazole (Ro 4-2130) 1000 μg/mL in methanol is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole 1000 μg/mL in methanol inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (HY-B1008) (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole 1000 μg/mL in methanol can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-P7037
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL2; T Cell Growth Factor; interleukin 2; Aldesleukin; IL-2; involved in Regulation Of T-Cell Clonal Expansion; TCGF; T-Cell Growth Factor; interleukin-2; Lymphokine
Species:  
Human
Source:  
E. coli
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-100004
CAS No.: 1644060-37-6
Purity:  99.14%
연구분야:  

Cancer

Fumarate hydratase-IN-1 (compound 2) is a cell-permeable fumarate hydratase inhibitor. Fumarate hydratase-IN-1 has antiproliferative activity against several cancer cell lines with a mean IC50 of 2.2 μM .
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-50737A
CAS No.: 924296-19-5
Target:  

Deubiquitinase

연구분야:  

Cancer

DUB-IN-2 is a potent deubiquitinase inhibitor with an IC50 of 0.28 μM for USP8 .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-148439
CAS No.: 2765081-21-6
Purity:  99.68%
Synonyms: RMC-6236; RAS-in-2
Target:  

Ras PERK

연구분야:  

Cancer

Daraxonrasib (RMC-6236) is an orally active, non-covalent RAS (ON) inhibitor. Daraxonrasib disrupts the interaction of wild-type or mutant RAS proteins with the RAS binding domain of BRAF, with EC50 values ranging from 28-220 nM for wild-type KRAS, NRAS, HRAS, and multiple oncogenic RAS variants. Daraxonrasib inhibits pERK. Daraxonrasib has anti-tumor activity against KRAS mutant tumors .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-12795
CAS No.: 1383716-33-3
Purity:  99.79%
Target:  

PI3K Autophagy

연구분야:  

Cancer

Vps34-IN-1 is a potent and selective inhibitor of class III Vps34 PI3K. Vps34-IN-1 inhibits phosphorylation of PtdIns by recombinant insect cell expressed Vps34-Vps15 complex with an IC50 of ~25 nM. Vps34-IN-1 can suppress SGK3 activation by reducing PtdIns(3)P levels via lowering phosphorylation of T-loop and hydrophobic motifs. Vps34-IN-1 modulates autophagy .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-14176
CAS No.: 209986-17-4
Purity:  99.97%
Synonyms: γ-Secretase-in-1
Target:  

γ-secretase

연구분야:  

Cancer

Compound E is a γ-secretase inhibitor. Compound E blocks β-amyloid(40), β-amyloid(42), and Notch γ-secretase cleavage with IC50s of 0.24, 0.37, 0.32 nM, respectively.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-12839
CAS No.: 1006378-90-0
Purity:  99.58%
Target:  

p38 MAPK Autophagy

연구분야:  

Inflammation/Immunology

p38 MAPK-IN-1 (Compound 4) is a novel potent and selective inhibitor of p38 MAPK with IC50 of 68 nM. p38 MAPK-IN-1 shows sustained levels, low clearance and good bioavailability.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-100198
CAS No.: 1881233-39-1
Purity:  99.84%
Target:  

PI4K PI3K

연구분야:  

Infection

PI4KIIIbeta-IN-10 is a potent PI4KIIIβ inhibitor with an IC50 of 3.6 nM.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-107575
CAS No.: 40592-88-9
Purity:  99.90%
연구분야:  

Inflammation/Immunology

TLR4-IN-C34 is an orally active TLR4 inhibitor and reduces systemic inflammation in models of endotoxemia and necrotizing enterocolitis .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-B0608
CAS No.: 18472-51-0
Chlorhexidine digluconate (20% in water) is a orally active cationic antimicrobial agent that targets microbial cell membranes. Chlorhexidine digluconate (20% in water) binds to cell membrane phospholipids non-specifically, destroys membrane structure and induces leakage of cell contents. Chlorhexidine digluconate (20% in water) has broad-spectrum bactericidal activity against both Gram-positive and Gram-negative bacteria. Chlorhexidine digluconate (20% in water) can interfere with membrane permeability, cause protein precipitation and energy metabolism disorders, such as rapid inhibition of microbial growth and induction of cell death (necrosis or apoptosis) .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-138682
CAS No.: 346691-38-1
Purity:  99.39%
STING-IN-2 (C-170) is a potent and covalent STING inhibitor. STING-IN-2 efficiently inhibits both mouse STING (mmSTING) and human STING (hsSTING). STING-IN-2 can be used for autoinflammatory disease research .
loading...
    loading...